KMT2A REARRANGEMENT
Clinical trials for KMT2A REARRANGEMENT explained in plain language.
Never miss a new study
Get alerted when new KMT2A REARRANGEMENT trials appear
Sign up with your email to follow new studies for KMT2A REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop leukemia relapse after transplant
Disease control Recruiting nowThis study looks at whether menin inhibitors can help prevent leukemia from coming back in patients who have had a stem cell transplant. About 20 adults with certain genetic types of acute leukemia will take these drugs as maintenance therapy. Researchers will track how many pati…
Matched conditions: KMT2A REARRANGEMENT
Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug aims to keep leukemia away after transplant
Disease control Recruiting nowThis early-phase study tests an investigational drug called ziftomenib in adults with acute myeloid leukemia (AML) who have had a stem cell transplant. The goal is to find a safe dose and see if the drug can help prevent the cancer from coming back. About 22 participants will tak…
Matched conditions: KMT2A REARRANGEMENT
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC